Genomics Led Discovery
While others look to data to answer their questions, we start by asking: what questions does the data content itself make possible?
Predictive Genomics
Since the human genome was announced in 2000, innovation in the field of genomic analysis has not matched advances in sequencing methods. We address this with Nomaly, a uniquely predictive AI engine.
Nomaly
Our AI engine predicts disease and phenotype directly from a single genome ab initio. Not by pattern-matching known genetic associations, but from fundamental molecular and cell biology. It's not trained to look for familiar variants or correlations. Instead, it uncovers the underlying biological mechanisms that actually drive and modulate disease.
Discovery and Precision
OutSee’s technologies can find additional results after other state-of-the-art methods have been fully exploited. We embrace standard approaches; by adding Nomaly we go beyond.
"Biology is still really hard. What people don't understand is that the problem of making a binder to a target is close to getting solved. The real question is what should you make binders to ..." Oct 2024, Nobel Prize winner David Baker on the future of AI in protein design — and beyond. Endpoints News
We can predict complex genetics including multi-variant effects and even mechanistically cooperative interactions. This allows us to group patients in ways that other methods can't — especially where traditional approaches struggle as the combinations of genetic factors become overwhelmingly complex.
While association-based methods depend heavily on cohort size, our predictive approach works equally well on small and large datasets, common and rare variation, or common and rare diseases.